Barbara Krebs

459 total citations
7 papers, 380 citations indexed

About

Barbara Krebs is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Barbara Krebs has authored 7 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Barbara Krebs's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and T-cell and B-cell Immunology (2 papers). Barbara Krebs is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and T-cell and B-cell Immunology (2 papers). Barbara Krebs collaborates with scholars based in Germany, United States and United Kingdom. Barbara Krebs's co-authors include Stefan Rose‐John, Michael Schauer, Stefan Zahn, Clark Q. Pan, Bodo Brocks, Blair U. Bradford, Adrian Tomkinson, Claudia Hirth‐Dietrich, Ellen Cheung and Christopher J. Parsons and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Immunological Methods.

In The Last Decade

Barbara Krebs

7 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Krebs Germany 7 190 151 132 115 57 7 380
Futoshi Kanke Japan 6 136 0.7× 27 0.2× 234 1.8× 200 1.7× 32 0.6× 9 396
André Roy Canada 11 265 1.4× 146 1.0× 67 0.5× 65 0.6× 116 2.0× 22 495
R. Williams United States 6 112 0.6× 26 0.2× 44 0.3× 31 0.3× 63 1.1× 13 289
Zhenqing Feng China 12 201 1.1× 43 0.3× 18 0.1× 27 0.2× 77 1.4× 30 408
HP Dienes Germany 8 159 0.8× 49 0.3× 66 0.5× 50 0.4× 80 1.4× 9 299
Lang Dou United Kingdom 6 92 0.5× 55 0.4× 34 0.3× 69 0.6× 198 3.5× 6 311
Anna Azvolinsky United States 10 584 3.1× 10 0.1× 73 0.6× 114 1.0× 29 0.5× 55 781
Luisa DeMarte Canada 9 190 1.0× 206 1.4× 9 0.1× 34 0.3× 74 1.3× 10 456
Jean Carol Hager United States 11 179 0.9× 38 0.3× 21 0.2× 23 0.2× 39 0.7× 20 366

Countries citing papers authored by Barbara Krebs

Since Specialization
Citations

This map shows the geographic impact of Barbara Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Krebs more than expected).

Fields of papers citing papers by Barbara Krebs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Krebs. The network helps show where Barbara Krebs may publish in the future.

Co-authorship network of co-authors of Barbara Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Krebs. A scholar is included among the top collaborators of Barbara Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Krebs. Barbara Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Brocks, Bodo, et al.. (2007). Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases. Human Antibodies. 15(4). 115–124. 10 indexed citations
2.
Parsons, Christopher J., Blair U. Bradford, Clark Q. Pan, et al.. (2004). Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology. 40(5). 1106–1115. 155 indexed citations
3.
Krebs, Barbara, Robert Rauchenberger, Silke U. Reiffert, et al.. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods. 254(1-2). 67–84. 130 indexed citations
4.
Krebs, Barbara, Heather Griffin, Greg Winter, & Stefan Rose‐John. (1998). Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6. Journal of Biological Chemistry. 273(5). 2858–2865. 24 indexed citations
5.
Krebs, Barbara, Birgit Ackermann, & Stefan Rose‐John. (1998). Specific Targeting of Cytokine-Secreting Cells: A Bispecific Diabody Recognizing Human Interleukin-6 and CD3 Induces T Cell-Mediated Killing. Journal of Interferon & Cytokine Research. 18(9). 783–791. 9 indexed citations
6.
Özbek, Suat, Joachim Grötzinger, Barbara Krebs, et al.. (1998). The Membrane Proximal Cytokine Receptor Domain of the Human Interleukin-6 Receptor Is Sufficient for Ligand Binding but Not for gp130 Association. Journal of Biological Chemistry. 273(33). 21374–21379. 32 indexed citations
7.
Wild, A., Barbara Krebs, & W. W. Rühle. (1980). Methodical Studies in the Separation of Chlorophyll-Protein Complexes by Polyacrylamide Gel Electrophoresis. Zeitschrift für Pflanzenphysiologie. 100(1). 1–13. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026